Background: We aimed to review the systematic economic evaluation of denosumab versus than alternative drugs and oral bisphosphonates of postmenopausal osteoporosis in women and help health system policy makers for prioritizing and optimally allocate limited health resources. Methods: We examined the databases of PubMed. Web of Science. Embase. https://www.roneverhart.com/HP-15-fc0093dx-15-6-FHD-Laptop-AMD-Ryzen-5-7520U-2-8-GHz-AMD-Radeon-16GB-LPDDR5-256GB-SSD-Windows-11-Home-S-8F1A6UA/